What is Rilpivirine-Tenofovir alafenamide-Emtricitabine?

Category: Prescription Drugs

Most popular types: Odefsey

false

The antiretroviral drugs rilpivirine, tenofovir alafenamide, and emtricitabine, and are combined to be taken as one tablet once a day. It may be prescribed for use alone as a complete treatment option or in combination with other antiretroviral medications.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 2

Commonly reported side effects and conditions associated with Rilpivirine-Tenofovir alafenamide-Emtricitabine

Side effect Patients Percentage

Dosages

Based on patients currently taking Rilpivirine-Tenofovir alafenamide-Emtricitabine

Dosage Patients Percentage
200-25-25 mg daily 1

Duration

Currently taking Rilpivirine-Tenofovir alafenamide-Emtricitabine

Duration Patients Percentage
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 1
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 0

What people switch to and from

Patients started taking Rilpivirine-Tenofovir alafenamide-Emtricitabine after stopping:

Treatment Patients Percentage
Rilpivirine-Tenofovir disoproxil fumarate-Emtricitabine (Complera) 3
Darunavir (DRV) (Prezista) 1
Raltegravir (RAL) (Isentress) 1
Last updated:
There are no evaluations for Rilpivirine-Tenofovir alafenamide-Emtricitabine.